📰 Linkedin News
Page 886 - Linkedin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Linkedin. Real-time updates on events, politics, business and more.
April 23, 2024
Lisa Talcott, formerly vice president of federal civilian sales at Dataminr, announced on LinkedIn Monday her new role as VP of regulatory programs at information technology services firm Procentrix. Talcott's other prior employers include NTT Data, where she spent much of her career.
April 23, 2024
NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx...
April 23, 2024
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of JBS S....
April 23, 2024
Glancy Prongay & Murray LLP reminds investors of the upcoming June 11, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise...
April 23, 2024
Chesapeake Financial Shares Reports First Quarter Earnings and Declares ...
April 23, 2024
/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of VinFast Auto Ltd. f/k/a Black Spade Acquisition...
April 23, 2024
Tuesday, April 23, 2024 SILICON SLOPES, Utah- At this years 10th annual Domopalooza, the AI and Data Conference, Domobrought together over a thousand attendees from some of the...
April 23, 2024
Medtronic (NYSE: MDT) company officials today shared that the medtech giant named Yarmela Pavlovic as its new chief regulatory officer.
April 23, 2024
The situation was brought into sharper focus by a viral LinkedIn post authored by a Google employee named Diane. In it, she criticized the company’s leadership and strategic direction. Her post resonated widely within and beyond Google, describing a pervasive atmosphere of cynicism and resignation among employees.
April 23, 2024
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17)...